Rexahn Pharmaceuticals Inc is a clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of treatments for cancer and other medical needs.
| Website: | www.rexahn.com |
| Email: | jurchisons@rexahn.com |
| Main Phone: | +1 240 268-5300 |
| Address: | 15245 Shady Grove Road |
| Address 2: | Suite 455 |
| State: | MD |
| City / Town: | Rockville |
| Country: | USA |
| Postal Code: | 20850 |
| Exchange: | AMX |
| Employees: | 20 |
| NAICS: | Pharmaceutical P |
| Last Price 1.83 | Change $ 0. | Change % 0.00 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask 2.41 | Ask Size 100.00 |
| Open 1.83 | High 1.87 | Low 1.78 | Prev Close 1.83 |
| Last Trade | Volume 79,780 | 52 Wk Hi 7.10 | 52 Wk Low 1.27 |
| Market Cap 52.1 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 28,459,805.00 | EPS (TTM) -0.97 | PE Ratio N/A | Exchange NYSE American |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 0 | 1 |
| Number of Buys | 0 | 1 |
| Number of Sells | 0 | 0 |
| Net Activity | 0 | 60000 |
| Last 10 Buys | Shares |
|---|---|
| Richard Kivel | 1,000 |
| Peter C. Brandt | 1,000 |
| Peter C. Brandt | 1,000 |
| Peter C. Brandt | 1,000 |
| Peter C. Brandt | 1,000 |
| Peter C. Brandt | 1,000 |
| Peter C. Brandt | 1,000 |
| Peter C. Brandt | 1,000 |
| Peter C. Brandt | 1,000 |
| Peter C. Brandt | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Chang Ho Ahn | 1,000 |
| Tae Heum Jeong | 1,000 |
| Chang Ho Ahn | 1,000 |
| Tae Heum Jeong | 1,000 |
| Chang Ho Ahn | 1,000 |
| Tae Heum Jeong | 1,000 |
| Chang Ho Ahn | 1,000 |
| Tae Heum Jeong | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 3 | 3 | 3 | 3 |
| Low Target Price Estimate | 3 | 2.5 | 2.5 | 3 |
| Mean Target Price Estimate | 3 | 2.75 | 2.75 | 3 |
| Standard Deviation | 0 | 0.35 | 0.35 | 0 |
| Date of Most Recent Estimate | 08/09/16 | 05/10/16 | 05/10/16 | 08/09/16 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 10-Q | Quarterly report with a continuing view of a company's financial position | 47 | 2016-08-05 |
| 8-K | Report of unscheduled material events or corporate changes. | 6 | 2016-07-11 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-07-08 |
| 3 | Initial statement of beneficial ownership of securities | 1 | 2016-07-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-10 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-10 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-10 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-10 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-06-10 |
| 8-K | Report of unscheduled material events or corporate changes. | 20 | 2016-06-10 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 3 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
